Opium (Opioid) Addiction Global Clinical Trials Review, H1, 2018

GlobalData's clinical trial report, “Opium (Opioid) Addiction Global Clinical Trials Review, H1, 2018" provides an overview of Opium (Opioid) Addiction clinical trials scenario. This report provides top line data relating to the clinical trials on Opium (Opioid) Addiction. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData’s proprietary database – Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

– The report provides a snapshot of the global clinical trials landscape

– Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status

– The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company

– The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment

– The Report provides enrollment trends for the past five years

– Report provides latest news for the past three months

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

Assists in formulating key business strategies with regards to investment

Helps in identifying prominent locations for conducting clinical trials which saves time and cost

Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities

Supports understanding of trials count and enrollment trends by country in global therapeutics market

Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials

Facilitates clinical trial assessment of the indication on a global, regional and country level

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Companies mentioned

Indivior Plc

Alkermes Plc

Mundipharma International Ltd

Orexo AB

Apple Tree Partners

Worldwide Clinical Trials Inc

Pfizer Inc

BioDelivery Sciences International Inc

Altasciences Company Inc

Insys Therapeutics Inc

Table of Contents

Table of Contents 2

List of Tables 4

List of Figures 5

Report Guidance 6

GlobalData Clinical Trials Report Coverage 7

Clinical Trials by Region 8

Clinical Trials and Average Enrollment by Country 9

Top Five Countries Contributing to Clinical Trials in Asia-Pacific 12

Top Five Countries Contributing to Clinical Trials in Europe 13

Top Countries Contributing to Clinical Trials in North America 14

Top Five Countries Contributing to Clinical Trials in Middle East and Africa 15

Top Countries Contributing to Clinical Trials in Central and South America 16

Clinical Trials by G7 Countries: Proportion of Opium (Opioid) Addiction to Central Nervous System Clinical Trials 17

Clinical Trials by Phase in G7 Countries 19

Clinical Trials in G7 Countries by Trial Status 20

Clinical Trials by E7 Countries: Proportion of Opium (Opioid) Addiction to Central Nervous System Clinical Trials 22

Clinical Trials by Phase in E7 Countries 24

Clinical Trials in E7 Countries by Trial Status 25

Clinical Trials by Phase 26

In Progress Trials by Phase 27

Clinical Trials by Trial Status 28

Clinical Trials by End Point Status 30

Subjects Recruited Over a Period of Time 31

Clinical Trials by Sponsor Type 32

Prominent Sponsors 33

Top Companies Participating in Opium (Opioid) Addiction Therapeutics Clinical Trials 35

Prominent Drugs 37

Latest Clinical Trials News on Opium (Opioid) Addiction 38

Apr 13, 2018: Patient-Reported Outcomes Data on SUBLOCADE (Buprenorphine Extended-Release) Injection to be Presented as Late-Breaker at American Society of Addiction Medicine (ASAM) 49th Annual Conference 38

Feb 13, 2018: Naltrexone transdermal patch (Nalsyn) has patent granted in USA 38

Clinical Trial Profile Snapshots 40

Appendix 361

Abbreviations 361

Definitions 361

Research Methodology 362

Secondary Research 362

About GlobalData 363

Contact Us 363

Source 364

List of Tables

Opium (Opioid) Addiction Therapeutics, Global, Clinical Trials by Region, 2018* 8

Opium (Opioid) Addiction Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2018* 9

Opium (Opioid) Addiction Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2018* 11

Opium (Opioid) Addiction Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2018* 12

Opium (Opioid) Addiction Therapeutics Clinical Trials, Europe, Top Five Countries, 2018* 13

Opium (Opioid) Addiction Therapeutics Clinical Trials, North America, Top Countries, 2018* 14

Opium (Opioid) Addiction Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2018* 15

Opium (Opioid) Addiction Therapeutics Clinical Trials, Central and South America, Top Countries, 2018* 16

Proportion of Opium (Opioid) Addiction to Central Nervous System Clinical Trials, G7 Countries (%), 2018* 17

Opium (Opioid) Addiction Therapeutics, G7 Countries, Clinical Trials by Phase, 2018* 19

Opium (Opioid) Addiction Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2018* 20

Proportion of Opium (Opioid) Addiction to Central Nervous System Clinical Trials, E7 Countries (%), 2018* 22

Opium (Opioid) Addiction Therapeutics, E7 Countries, Clinical Trials by Phase, 2018* 24

Opium (Opioid) Addiction Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2018* 25

Opium (Opioid) Addiction Therapeutics, Global, Clinical Trials by Phase, 2018* 26

Opium (Opioid) Addiction Therapeutics, Global, Clinical Trials In Progress by Phase 2018* 27

Opium (Opioid) Addiction Therapeutics, Global, Clinical Trials by Trial Status, 2018* 28

Opium (Opioid) Addiction Therapeutics Clinical Trials, Global, by End Point Status, 2018* 30

Opium (Opioid) Addiction Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2013-2017 31

Opium (Opioid) Addiction Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2018* 32

Opium (Opioid) Addiction Therapeutics Clinical Trials, Global, Key Sponsors, 2018* 33

Opium (Opioid) Addiction Therapeutics Clinical Trials, Global, Top Companies by Phase, 2018* 35

Opium (Opioid) Addiction Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2018* 37

List of Figures

Opium (Opioid) Addiction Therapeutics, Global, Clinical Trials by Region (%), 2018* 8

Opium (Opioid) Addiction Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2018* 9

Opium (Opioid) Addiction Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2018* 11

Opium (Opioid) Addiction Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2018* 12

Opium (Opioid) Addiction Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2018* 13

Opium (Opioid) Addiction Therapeutics Clinical Trials, North America, Top Countries (%), 2018* 14

Opium (Opioid) Addiction Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2018* 15

Opium (Opioid) Addiction Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2018* 16

Proportion of Opium (Opioid) Addiction to Central Nervous System Clinical Trials, G7 Countries (%), 2018* 17

Opium (Opioid) Addiction Therapeutics, G7 Countries, Clinical Trials by Phase, 2018* 19

Opium (Opioid) Addiction Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2018* 20

Proportion of Opium (Opioid) Addiction to Central Nervous System Clinical Trials, E7 Countries (%), 2018* 22

Opium (Opioid) Addiction Therapeutics, E7 Countries, Clinical Trials by Phase, 2018* 24

Opium (Opioid) Addiction Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2018* 25

Opium (Opioid) Addiction Therapeutics, Global, Clinical Trials by Phase (%), 2018* 26

Opium (Opioid) Addiction Therapeutics, Global, Clinical Trials In Progress by Phase, 2018* 27

Opium (Opioid) Addiction Therapeutics, Global, Clinical Trials by Trial Status, 2018* 28

Opium (Opioid) Addiction Therapeutics Clinical Trials, Global, by End Point Status, 2018* 30

Opium (Opioid) Addiction Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2013-2017 31

Opium (Opioid) Addiction Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2018* 32

Opium (Opioid) Addiction Therapeutics Clinical Trials, Global, Key Sponsors, 2018* 33

Opium (Opioid) Addiction Therapeutics Clinical Trials, Global, Top Companies by Phase, 2018* 35

Opium (Opioid) Addiction Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2018* 37

GlobalData Methodology 362

    Pricing

Discounts available for multiple report purchases.

reportstore@globaldata.com
+44 20 7947 2745

Join our mailing list

Saved reports